Projects per year
Search results
-
Active
A PHASE 1, OPEN-LABEL, MULTICENTER STUDY OF JANX007 IN SUBJECTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Heyne, K. (Key Personnel), Miles, B. J. (Key Personnel), Satkunasivam, R. (Key Personnel), Singh, M. (Key Personnel) & Zhang, J. (Key Personnel)
10/17/24 → …
Project: Clinical Trial
-
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Niravath, P. A. (PI), Antosh, D. (Key Personnel), Chang, J. C. (Key Personnel), High, R. A. (Key Personnel), Hoopes, S. (Key Personnel), Mai, H. P. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel) & Zaid, T. (Key Personnel)
5/17/24 → …
Project: Clinical Trial
-
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study
Abdelrahim, M. (PI), Connor, A. A. (Key Personnel), Ghobrial, R. M. (Key Personnel), Gibbs, J. M. (Key Personnel), Graviss, E. A. (Key Personnel), Gupta, N. (Key Personnel), Kodali, S. (Key Personnel), Mobley, C. M. (Key Personnel), Moore, L. W. (Key Personnel), Rizk, E. (Key Personnel), Saharia, A. (Key Personnel), Singh, M. (Key Personnel) & Victor, III, D. W. (Key Personnel)
1/18/23 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A. (PI), Alaniz, A. (CoI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/15/21 → 3/14/46
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C. (PI), Bernicker, E. H. (Key Personnel), Darcourt, J. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
4/9/20 → …
Project: Clinical Trial
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
3/6/20 → 3/5/45
Project: Non Profit
-
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864)) in addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Kamat, A. A. (PI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/1/19 → 2/28/25
Project: Non Profit
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Darcourt, J. (Key Personnel), Pingali, S. R. (Key Personnel), Sahay, S. (Key Personnel), Shah, S. (Key Personnel), Singh, M. (Key Personnel), Zhang, J. (Key Personnel), Zhou, S. (Key Personnel) & Zu, Y. (Key Personnel)
1/10/19 → …
Project: Clinical Trial
-
TAILOR RT: A RANDOMIZED TRIAL OF REGIONAL RADIOTHERAPY IN BIOMARKER LOW RISK NODE POSITIVE AND T3N0 BREAST CANCER
Teh, B. S. (PI), Chang, J. C. (CoI), Farach, A. M. (CoI), Haque, W. M. (CoI), Morgan, P. B. (CoI), Niravath, P. A. (CoI), Shadle, K. M. (CoI), Shkedy, C. (CoI) & Singh, M. (CoI)
5/30/18 → 5/29/28
Project: Non Profit
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A. (PI), Alaniz, A. (CoI), Bernicker, E. H. (CoI), Darcourt, J. (CoI), Heyne, K. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/13/18 → 3/12/43
Project: Non Profit
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C. (PI), Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
12/8/16 → 12/7/41
Project: Non Profit
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H. (PI), Chang, J. C. (CoI), Darcourt, J. (CoI), Heyne, K. (CoI), Kamat, A. A. (CoI), Pingali, S. R. (CoI) & Singh, M. (CoI)
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
Stem Cell: Biomarkers Including Putative Stem Cells Markers in Human Breast Cancers
Chang, J. C. (PI), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel), Singh, M. (Key Personnel) & Templeton, S. (Key Personnel)
3/20/14 → …
Project: Clinical Trial
-
Metastatic Stem Cells-ROLE OF CANCER STEM CELLS IN BREAST CANCER RECURRENCE AND METASTASIS
Chang, J. C. (PI), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
3/20/14 → …
Project: Clinical Trial
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T. (PI), Butler, E. B. (CoI), Darcourt, J. (CoI), Farach, A. M. (CoI), Kamat, A. A. (CoI), Shkedy, C. (CoI), Singh, M. (CoI) & Suri, A. (CoI)
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab (IND #134427) Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in P
Kamat, A. A. (PI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/1/14 → 2/28/39
Project: Non Profit
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M. (PI), Bernicker, E. H. (CoI), Darcourt, J. (CoI), Heyne, K. (CoI) & Singh, M. (CoI)
3/1/14 → 2/28/39
Project: Non Profit
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H. (Key Personnel), Darcourt, J. (Key Personnel) & Singh, M. (Key Personnel)
8/13/13 → 8/12/38
Project: Non Profit
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H. (Project Director), Darcourt, J. (Project Director) & Singh, M. (Project Director)
6/11/13 → 6/10/38
Project: Non Profit
-
CAN DIET AND PHYSICAL ACTIVITY MODULATE OVARIAN, FALLOPIAN TUBE AND PRIMARY PERITONEAL CANCER PROGRESSION-FREE SURVIVAL?
Kamat, A. A. (PI), Kaplan, A. L. (CoI) & Singh, M. (CoI)
5/14/13 → 5/13/38
Project: Non Profit
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
Chang, J. C. (CoI) & Singh, M. (CoI)
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-